GM-CSF-mediated epithelial-immune cell cross-talk orchestrates pulmonary immunity to Aspergillus fumigatus

Area of Science:

• Immunology
• Pulmonology
• Microbiology

Background:

• Invasive aspergillosis, a severe pneumonia, disproportionately affects immunocompromised individuals with neutrophil deficiencies.
• While innate immune cells coordinate neutrophil antifungal responses in the lungs, the contribution of epithelial cells remains unclear.

Purpose of the Study:

• To investigate the role of lung epithelial cells in orchestrating neutrophil-mediated immunity against Aspergillus fumigatus.
• To identify the mechanisms by which epithelial cells contribute to host defense against inhaled fungal pathogens.

Main Methods:

• Utilized in vivo models of fungal pneumonia.
• Analyzed the integration of interleukin-1 and type III interferon signaling in lung epithelial cells.
• Assessed the production and function of granulocyte-macrophage colony-stimulating factor (GM-CSF) in response to Aspergillus fumigatus infection.

Main Results:

• Surfactant protein C (SPC)-expressing lung epithelial cells were found to produce GM-CSF at sites of fungal infection and neutrophil infiltration.
• Epithelial-derived GM-CSF was shown to enhance neutrophil accumulation and increase their fungicidal activity.
• This epithelial-derived GM-CSF is essential for host survival during acute fungal infection.

Conclusions:

• SPC-expressing lung epithelial cells are key regulators of neutrophil antifungal immunity.
• These cells integrate inflammatory signals to produce GM-CSF, thereby boosting neutrophil function.
• Targeting epithelial cell-derived GM-CSF may offer a therapeutic strategy against invasive aspergillosis.